Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) NSE
201.74
+0.14(+0.07%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.5B |
| Enterprise Value | 12.48B |
| P/E Ratio | 32.8 |
| PEG Ratio | -1.46 |
| Price/Sales Ratio | 4.71 |
| Price/Book Ratio | 5.12 |
| Enterprise/Revenue | 4.71 |
| Enterprise/EBITDA | 19.88 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.17 |
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 2.87B |
| Revenue/Share | 40.98 |
| Gross Profit | 1.83B |
| EBITDA | 679.9M |
| Net Income | 430.82M |
| Diluted EPS | 6.31 |
Balance Sheet
| Total Cash | 1.06B |
| Total Cash/Share | 15.15 |
| Total Debt | 81.65M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 5.06 |
| Book Value Per Share | 39.4 |
Price History
| 52-Week Change | -14.97 |
| 52-Week High | 301.65 |
| 52-Week Low | 155 |
| Moving Average 50 Days | 199.06 |
| Moving Average 200 Days | 201.4 |
Statistics
| Average Volume | 233,876 |
| Shares Outstanding | 67.14M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.5 |
| Trailing Annual Dividend Yield | 1.24 |
| Payout Ratio | 0.39 |
| Last Split Factor | 8:1 |
| Last Split Date | July 20, 2004 |
